Glenn Pierce

Chief Medical Officer & Senior Vice President at Bioverativ Therapeutics, Inc.

Glenn Pierce

Glenn Pierce

Chief Medical Officer & Senior Vice President at Bioverativ Therapeutics, Inc.

Overview
Career Highlights

National Hemophilia Foundation

RelSci Relationships

1642

Number of Boards

4

Birthday

1956

Age

64

Relationships
RelSci Relationships are individuals Glenn Pierce likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director, Marketing & Community Relations at Bioverativ Therapeutics, Inc.

Relationship likelihood: Strong

Former Venture Partner at Third Rock Ventures LLC

Relationship likelihood: Strong

Partner, Samsara Biocapital at Intellia Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Strong

Former Chief Financial Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Partner at Third Rock Ventures LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Global Blood Therapeutics, Inc.

Relationship likelihood: Strong

Executive Officer, Director at Adolor Corp.

Relationship likelihood: Strong

Former President of Genzyme Europe & General Manager of Cardiovascular Business at Genzyme Corp.

Relationship likelihood: Strong

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Strong

Paths to Glenn Pierce
Potential Connections via
Relationship Science
You
Glenn Pierce
Chief Medical Officer & Senior Vice President at Bioverativ Therapeutics, Inc.
Education
Ph.D. Immunology & Experimental Pathology

Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH.

The mission of Washington University in St. Louis is the promotion of learning — learning by students and by faculty. Teaching, the transmission of knowledge, is central to our mission, as is research, the creation of new knowledge. Faculty — composed of scholars, scientists, artists and members of the learned professions — serve society by teaching; by adding to the store of human art, creativity, understanding, and wisdom; and by providing direct services, such as health care. The university offers more than 90 programs and almost 1,500 courses leading to bachelor's, master's and doctoral degrees in a broad spectrum of traditional and interdisciplinary fields, with additional opportunities for minor concentrations and individualized programs.

Memberships
Member
Current

The American Society of Hematology 's mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

Member
Current

TO FURTHER RESEARCH & EDUCATION ON THE MAJOR DISEASE OF THROMBOSIS AND DISORDERS OF HAEMOSTASIS.

Member
Current

HTRS PROGRAMMING IN 2018 FEATURED THE 2018 HTRS/NASTH RESEARCH COLLOQUIUM: "DEVELOPING A SUSTAINABLE RESEARCH CAREER IN HEMOSTASIS AND THROMBOSIS" (THE "COLLOQUIUM"). THE COLLOQUIUM WAS A DYNAMIC, 1.5-DAY EDUCATIONAL AND CAREER DEVELOPMENT EVENT BEING HELD MARCH 6-7, 2018 AT THE HILTON SAN DIEGO AIRPORT/HARBOR ISLAND IN SAN DIEGO, CA. THE COLLOQUIUM WAS THE FIRST MEETING OF ITS KIND TO BE OFFERED JOINTLY BY HTRS AND NASTH, TWO U.S.-BASED NONPROFIT PROFESSIONAL MEDICAL SOCIETIES. TOGETHER, MEMBERS OF HTRS AND NASTH REPRESENT THE FULL SPECTRUM OF U.S. CLINICAL, TRANSLATIONAL, AND BASIC SCIENCE RESEARCHERS DEDICATED TO ADVANCING RESEARCH IN HEMOPHILIA AND OTHER NON-MALIGNANT BLOOD DISORDERS.

Career History
Chief Medical Officer
2018 - Current

Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA.

Chief Medical Officer & Senior Vice President
2009 - Current

Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA.

Entrepreneur-in-Residence
Current

Third Rock Ventures invests in companies located in the US. The firm targets operating in the fields of healthcare sector. It provides financing for early-stage capital requirements. It also acts as a lead investor.

Boards & Committees
Director
2015 - Current
Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Glenn Pierce. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Glenn Pierce's profile does not indicate a business or promotional relationship of any kind between RelSci and Glenn Pierce.